Farydak Side Effects
Generic name: panobinostat
Medically reviewed by Drugs.com. Last updated on Oct 29, 2024.
Note: This document provides detailed information about Farydak Side Effects associated with panobinostat. Some dosage forms listed on this page may not apply specifically to the brand name Farydak.
Applies to panobinostat: oral capsule.
Important warnings
This medicine can cause some serious health issues
Oral route (capsule)
Severe diarrhea has been reported with panobinostat.
Monitor for diarrhea, institute antidiarrheal treatment, interrupt therapy, then reduce the dose or discontinue panobinostat if necessary for severe diarrhea.
Severe and fatal cardiac ischemic events, severe arrhythmias, and ECG changes have occurred in patients receiving panobinostat, and electrolyte abnormalities may exacerbate arrhythmias.
A baseline ECG and electrolyte panel is recommended, along with periodic monitoring during treatment as clinically indicated.
Precautions
It is very important that your doctor check your progress while you are using this medicine to see if it is working properly and to check for unwanted effects. Blood tests may be needed to check for unwanted effects.
Using this medicine while you are pregnant can harm your unborn baby. Use an effective form of birth control (eg, condoms) to keep from getting pregnant during therapy and for 1 month after the last dose (for sexually-active females), and for 3 months after the last dose (for sexually-active men). If you think you or your partner have become pregnant while using the medicine, tell your doctor right away.
Cancer medicines can cause diarrhea, nausea, or vomiting in most people, sometimes even after receiving medicines to prevent it. Ask your doctor or nurse about other ways to control these side effects.
Contact your doctor right away if you have any changes to your heart rhythm. You might feel dizzy or faint, or you might have a fast, pounding, or uneven heartbeat. Make sure your doctor knows if you or anyone in your family has ever had a heart rhythm problem such as QT prolongation.
Panobinostat can temporarily lower the number of white blood cells in your blood, increasing the chance of getting an infection. It can also lower the number of platelets, which are necessary for proper blood clotting. If this occurs, there are certain precautions you can take, especially when your blood count is low, to reduce the risk of infection or bleeding:
- If you can, avoid people with infections. Check with your doctor immediately if you think you are getting an infection or if you get a fever or chills, cough or hoarseness, lower back or side pain, or painful or difficult urination.
- Check with your doctor immediately if you notice any unusual bleeding or bruising, black, tarry stools, blood in the urine or stools, or pinpoint red spots on your skin.
- Be careful when using a regular toothbrush, dental floss, or toothpick. Your medical doctor, dentist, or nurse may recommend other ways to clean your teeth and gums. Check with your medical doctor before having any dental work done.
- Do not touch your eyes or the inside of your nose unless you have just washed your hands and have not touched anything else in the meantime.
- Be careful not to cut yourself when you are using sharp objects such as a safety razor or fingernail or toenail cutters.
- Avoid contact sports or other situations where bruising or injury could occur.
This medicine may increase your risk of developing infections. Avoid being near people who are sick or have infections while you are using this medicine. Wash your hands often. Tell your doctor if you have any kind of infection before you start using this medicine. Also tell your doctor if you have ever had an infection that would not go away or an infection that kept coming back.
Check with your doctor right away if you have pain or tenderness in the upper stomach, pale stools, dark urine, loss of appetite, nausea, vomiting, or yellow eyes or skin. These could be symptoms of a serious liver problem.
Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.
Serious side effects of Farydak
Along with its needed effects, panobinostat (the active ingredient contained in Farydak) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking panobinostat:
More common side effects
- abdominal or stomach pain or tenderness
- black, tarry stools
- bloating or swelling of the face, arms, hands, lower legs, or feet
- clay colored stools
- confusion
- cough or sore throat
- dark or bloody urine
- decreased appetite
- decreased frequency or amount of urine
- dizziness, faintness, or lightheadedness especially when getting up suddenly from a lying or sitting position
- fast, irregular, pounding, or racing heartbeat or pulse
- fever, chills, or sweating
- headache
- increased thirst
- itching or skin rash
- loss of appetite
- lower back or side pain
- muscle spasms or twitching
- nausea or vomiting
- nervousness
- painful or difficult urination
- pinpoint red spots on the skin
- pounding in the ears
- rapid breathing
- seizures
- severe diarrhea
- slow or fast heartbeat
- swelling of the face, fingers, feet, or lower legs
- tingling of the hands or feet
- trouble breathing
- ulcers, sores, or white spots in the mouth
- unusual bleeding or bruising
- unusual tiredness or weakness
- unusual weight gain or loss
- yellow eyes or skin
Less common side effects
- chest pain or discomfort
- coughing up blood
- difficulty with swallowing
- increased menstrual flow or vaginal bleeding
- nosebleeds
- pain in the shoulders, arms, jaw, or neck
- paralysis
Other side effects of Farydak
Some side effects of panobinostat may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
- acid or sour stomach
- belching or passing gas
- change or loss in taste
- depressed mood
- dry mouth
- hair loss
- heartburn or indigestion
- hoarseness or husky voice
- fatigue or feeling lethargic
- redness of the skin
For healthcare professionals
Applies to panobinostat: oral capsule.
Gastrointestinal adverse events
- Very common (10% or more): Diarrhea (68%), nausea (36%), vomiting (26%)
- Common (1% to 10%): Abdominal pain, dyspepsia, gastritis, cheilitis, abdominal distension, dry mouth, flatulence, colitis, gastrointestinal pain
Cardiovascular
- Very common (10% or more): T-wave abnormalities (40%), ST-segment depression (22%), arrhythmia (12%)
- Common (1% to 10%): Palpitations, hypotension, hypertension, orthostatic hypotension
- Uncommon (0.1% to 1%): Cardiac ischemic events[Ref]
Hematologic
- Very common (10% or more): Thrombocytopenia (97%), lymphopenia (82%), leukopenia (81%), neutropenia (75%), anemia (62%)
- Common (1% to 10%): Grade 3/4 hemorrhage
Immunologic
- Very common (10% or more): Severe infections (31%)
- Common (1% to 10%): Hepatitis B
Hepatic
- Common (1% to 10%): Increased blood alkaline phosphatase
- Frequency not reported: Hepatic dysfunction (primarily aminotransferase and total bilirubin elevations)
Metabolic
- Very common (10% or more): Hypocalcemia (67%), hypoalbuminemia (63%), hypophosphatemia (63%), hypokalemia (52%), hyponatremia (49%), hyperphosphatemia (29%), decreased appetite (28%), hypermagnesemia (27%), hyperbilirubinemia (21%), decreased weight (12%)
- Common (1% to 10%): Hyperglycemia, dehydration, fluid retention, hypomagnesemia
Dermatologic
- Common (1% to 10%): Skin lesions, rash, erythema
Endocrine
- Common (1% to 10%): Hypothyroidism
Genitourinary
- Common (1% to 10%): Urinary incontinence, hyperuricemia
Musculoskeletal
- Common (1% to 10%): Joint swelling
Nervous system
- Common (1% to 10%): Dizziness, headache, syncope, tremor, dysgeusia
Other
- Very common (10% or more): Fatigue (60%), peripheral edema (29%), pyrexia (26%)
- Common (1% to 10%): Chills
Psychiatric
- Common (1% to 10%): Insomnia
Renal
- Very common (10% or more): Increased blood creatinine (41%)
- Common (1% to 10%): Renal failure, increased blood urea, decreased glomerular filtration rate
Respiratory
- Common (1% to 10%): Cough, dyspnea, respiratory failure, rales, wheezing
See also:
Abecma
Abecma is a CAR T cell therapy used to treat relapsed refractory multiple myeloma (RRMM); it is a ...
Tecvayli
Tecvayli (teclistamab) is a treatment for relapsed or refractory multiple myeloma. Includes ...
Carvykti
Carvykti (ciltacabtagene autoleucel) is a treatment for relapsed or refractory multiple myeloma ...
Talvey
Talvey is used to treat relapsed or refractory multiple myeloma. Includes Talvey side effects ...
Decadron
Decadron is used for addison's disease, adrenal insufficiency, adrenocortical insufficiency ...
Revlimid
Revlimid is used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma and ...
Darzalex
Darzalex (daratumumab) is a target therapy used to treat multiple myeloma. Includes DARZALEX uses ...
Velcade
Velcade injection is used to treat multiple myeloma and mantle cell lymphoma. Includes Velcade side ...
Pomalyst
Pomalyst (pomalidomide) is used to treat multiple myeloma and AIDS-related Kaposi sarcoma. Includes ...
References
1. (2015) "Product Information. Farydak (panobinostat)." Novartis Pharmaceuticals
More about Farydak (panobinostat)
- Check interactions
- Compare alternatives
- Drug images
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: histone deacetylase inhibitors
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Farydak side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.